Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating
- PMID: 25838140
- PMCID: PMC4529062
- DOI: 10.1016/j.mehy.2015.03.020
Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating
Abstract
Dietary chromium supplementation for the treatment of diabetes remains controversial. The prevailing view that chromium supplementation for glucose regulation is unjustified has been based upon prior studies showing mixed, modest-sized effects in patients with type 2 diabetes (T2DM). Based on chromium's potential to improve insulin, dopamine, and serotonin function, we hypothesize that chromium has a greater glucoregulatory effect in individuals who have concurrent disturbances in dopamine and serotonin function--that is, complex patients with comorbid diabetes, depression, and binge eating. We propose, as suggested by the collective data to date, the need to go beyond the "one size fits all" approach to chromium supplementation and put forth a series of experiments designed to link physiological and neurobehavioral processes in the chromium response phenotype.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study.J Psychosom Res. 2013 Jul;75(1):36-42. doi: 10.1016/j.jpsychores.2013.03.092. Epub 2013 Apr 22. J Psychosom Res. 2013. PMID: 23751236 Free PMC article. Clinical Trial.
-
Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes: response to Martin et al.Diabetes Care. 2006 Dec;29(12):2764; author reply 2764-5. doi: 10.2337/dc06-1719. Diabetes Care. 2006. PMID: 17130232 No abstract available.
-
Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes.Int J Vitam Nutr Res. 2000 Jan;70(1):14-8. doi: 10.1024/0300-9831.70.1.14. Int J Vitam Nutr Res. 2000. PMID: 10683756
-
The safety and efficacy of high-dose chromium.Altern Med Rev. 2002 Jun;7(3):218-35. Altern Med Rev. 2002. PMID: 12126463 Review.
-
Chromium Supplementation in Human Health, Metabolic Syndrome, and Diabetes.Met Ions Life Sci. 2019 Jan 14;19:/books/9783110527872/9783110527872-015/9783110527872-015.xml. doi: 10.1515/9783110527872-015. Met Ions Life Sci. 2019. PMID: 30855110 Review.
Cited by
-
Effect of a high-fat diet and chromium on hormones level and Cr retention in rats.J Endocrinol Invest. 2022 Mar;45(3):527-535. doi: 10.1007/s40618-021-01677-3. Epub 2021 Sep 22. J Endocrinol Invest. 2022. PMID: 34550535 Free PMC article.
-
Effects of 12 Weeks of Chromium, Phyllanthus emblica Fruit Extract, and Shilajit Supplementation on Markers of Cardiometabolic Health, Fitness, and Weight Loss in Men and Women with Risk Factors to Metabolic Syndrome Initiating an Exercise and Diet Intervention: A Randomized Double-Blind, Placebo-Controlled Trial.Nutrients. 2025 Jun 19;17(12):2042. doi: 10.3390/nu17122042. Nutrients. 2025. PMID: 40573153 Free PMC article. Clinical Trial.
-
Chromium Supplementation; Negotiation with Diabetes Mellitus, Hyperlipidemia and Depression.J Diabetes Metab Disord. 2020 Mar 5;19(1):585-595. doi: 10.1007/s40200-020-00501-8. eCollection 2020 Jun. J Diabetes Metab Disord. 2020. PMID: 32550211 Free PMC article. Review.
-
Progress and trends of research on mineral elements for depression.Heliyon. 2024 Jul 31;10(15):e35469. doi: 10.1016/j.heliyon.2024.e35469. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170573 Free PMC article.
-
A Systematic Review of Dietary Supplements and Alternative Therapies for Weight Loss.Obesity (Silver Spring). 2021 Jul;29(7):1102-1113. doi: 10.1002/oby.23110. Obesity (Silver Spring). 2021. PMID: 34159755 Free PMC article.
References
-
- International Diabetes Federation. IDF Diabetes Atlas Update 2012. 2012 Available at: http://www.idf.org/diabetesatlas/5e/Update2012. - PubMed
-
- Korkiakangas EE, Alahuhta MA, Laitinen JH. Barriers to regular exercise among adults at high risk or diagnosed with type 2 diabetes: a systematic review. Health Promot Int. 2009;4(24):416–427. - PubMed
-
- Davison KM. Eating disorders and diabetes: Current perspectives. Can J Diabetes. 2003;1(27):62–73.
-
- Rotella F, Cresci B, Monami M, et al. Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study. Acta Diabetol. 2012;49(Suppl 1):179–184. - PubMed
-
- de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;4(63):619–630. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical